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INTRODUCTION

ABSTRACT
BACKGROUND: External cephalic version (ECV) can be a
helpful procedure in attempts to decrease the overall cesarean section rate. ECV involves the application of external pressure to the pregnant woman’s abdomen in attempts to turn
the fetus to a vertex presentation and allow for subsequent
vaginal delivery. Tocolytics are routinely used to increase ECV
success rates, and neuraxial analgesia has been presented
as another adjunct to increase overall success. The purpose
of this quality improvement project is to evaluate the effect
neuraxial analgesia may have on ECV success rates.
METHODS: Patients scheduled for ECV between the dates
of January 2020 and September 2021 were reviewed. Data
collected includes patient age, BMI, gestational age, success
of ECV and use of neuraxial analgesia (epidural anesthesia).
RESULTS: Of the 21 patients, 6 (29%) were found to be vertex on their scheduled ECV date. Six (29%) patients who did
not have an epidural failed ECV. Four (19%) patients who had
an epidural failed ECV. Five (24%) patients who had an epidural had a successful ECV. Interestingly, no patients had a
successful ECV without an epidural.
CONCLUSION: No attempts at ECV were successful without
an epidural in the 21 patient charts reviewed. Further evaluation through expanded chart review to increase the sample
size would allow for meaningful statistical evaluation of this
salient finding.
KEYWORDS: external cephalic version, neuraxial anesthesia,
cesarean section
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n the United States, the average rate
of cesarean delivery is 31.7%.1 External cephalic version (ECV), which
involves applying external pressure to a
woman’s abdomen to turn the fetus, is a
viable option to attempt to increase the
proportion of vertex presentations.2 This
technique can be helpful to decrease the
overall cesarean section rate. Previous research is encouraging regarding neuraxial
anesthesia impacting success rates of ECV.
In a meta-analysis by Magro-Malosso et
al, which reviewed nine randomized clinical trials, women who received neuraxial
anesthesia had a significantly higher incidence of successful external cephalic version, cephalic presentation in labor, and
vaginal delivery compared to those who
did not.3 Neuraxial anesthesia in combination with tocolytic therapy may also
increase ECV success rate.2 Another meta-analysis by Goetzinger et al also found
that regional anesthesia was associated
with higher ECV success.4 Furthermore,
both spinal and epidural anesthesia were
associated with increased ECV success.4
The current standard of care at Reading
Hospital for ECV includes the use of terbutaline (a tocolytic), with neuraxial analgesia left to provider and patient shared
decision making. The purpose of this quality improvement project is to evaluate the
success rate of external cephalic version
when neuraxial anesthesia (in the form of
epidural anesthesia) is utilized versus no
neuraxial anesthesia at the Reading Hospital/Tower Health labor and delivery unit.
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METHODS

RESULTS

Patients who were scheduled for external cephalic
versions from January 2020 to September 2021 were
compiled by encounter type and reviewed. A total of
21 patient charts were identified as being scheduled for
an external cephalic version (ECV) during this time
frame and were included in a manual chart review.
Specific demographic data was collected for each patient who was scheduled for an ECV which included:
gestational age at the time of ECV, patient age and patient BMI. Outcomes were then stratified into 5 main
groups which included: patients who had fetal vertex
presentation on admission and thus were discharged
without ECV attempt, patients who did not receive
neuraxial analgesia and version was unsuccessful, patients who did not receive neuraxial analgesia and version was successful, patients who did receive neuraxial
analgesia and version was unsuccessful, and patients
who did receive neuraxial analgesia and version was
successful. All patients received a tocolytic (terbutaline) prior to attempted ECV as per routine protocol. Fetal monitoring was performed prior to and after
the version attempts for all patients. The decision to
administer neuraxial analgesia was left up to the discretion of the attending physician after a discussion
with the patient. Given the small sample size, the goal
of this chart review was to identify any salient findings that may elucidate avenues for further inquiry by
larger chart review, as meaningful statistical analysis
could not be performed with the evaluated sample size.
SQUIRE 2.0 guidelines were followed in the writing
of this manuscript.5

Table 1 summarizes the findings of the chart review
performed. Of the 21 patients, six (29%) were found
to be vertex on their scheduled ECV date. Six (29%)
patients who did not have an epidural failed ECV. Four
(19%) patients who had an epidural failed ECV. Five
(24%) patients who had an epidural had a successful
ECV. Interestingly, no patients had a successful ECV
without an epidural. No complications were reported
related to attempted ECV’s such as rupture of membranes, cord prolapse, terminal fetal bradycardia, placental abruption or need for emergent cesarean delivery. The average BMI of patients who received an
epidural was lower compared to patients who did not
receive an epidural. Patients who failed ECV with an
epidural were older on average compared to the other
groups. An additional piece of data collected was the
type of delivery the patient ultimately had, regardless
of ECV success. Unfortunately, 5 of the 21 patients
transferred care to an outside facility with delivery type
not available for review. Given the small sample size,
with nearly one fourth of the patients delivering at outside facilities, mode of delivery (vaginal or cesarean
section) was not evaluated further.
DISCUSSION
Perhaps the most salient finding from the limited sample size included in this quality improvement project
was that no patients had a successful ECV if they did
not have an epidural. For patients who did have an epidural, four of them were unsuccessful while five were
successful. This finding of decreased success without

Table 1. Summary of Patient Findings
Vertex on
Presentation

Failed without
Epidural

Successful
without Epidural

Failed with
Epidural

Successful
with epidural

6

6

0

4

5

36w4d – 40w5d

37w3d – 38w5d

N/A

Average BMI

32.8

33.9

N/A

29.5

28.9

Average age

26.3

24.5

N/A

31

29.4

Total Number
of Patients
Gestational
Age Range
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an epidural mirror the findings of previous studies
which mentioned greater success rates with the use of
neuraxial anesthesia. Additional factors influence the
success of ECV aside from neuraxial anesthesia, such
as BMI, parity, placental location and type of fetal malpresentation.6 Success of ECV decreases with nulliparity, higher BMI and anterior placental location.6
The largest limitation related to this quality improvement project is the small sample size. Approximately
3% of fetuses are in breech presentation at term, so the
population in which an ECV can be offered is quite low.
Additionally, patients have the option to decline a version in favor of a cesarean section which further lowers
the total amount of versions performed. An additional
limitation includes the varied experience of providers
performing the ECV (resident physician compared to
attending physicians among different practices). Placental location and parity were not assessed in this review, which may factor into overall success rates.
No ECV attempts were successful without an epidural,
prompting further inquiry through a larger chart review
to increase the sample size and allow for meaningful
statistical analysis or a future randomized trial. Pending further study, the goal of this project moving forward is to develop a policy or checklist for analgesia
in patients scheduled for external cephalic version to
allow for consistent patient care and improved satisfaction and outcomes.
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